Robert Orenstein, DO

Infectious Disease Specialist
Mayo Clinic in Arizona
Phoenix, AZ, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 40 - Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial

  On Demand